MiRus has received FDA breakthrough device designation for its Europa posterior cervical system, designed for patients undergoing cervical and upper thoracic spinal fusion. The system features a smaller-diameter alloy rod for minimally invasive surgery. This designation is aimed at reducing the rates of spine implant failures and revision surgeries. Jordan Bauman, vice president of quality and regulatory affairs at MiRus, stated that this advancement will allow spine surgeons to provide more durable and less invasive surgery for their cervicothoracic patients. MiRus continues to work towards providing less invasive and more durable devices for a wide range of medical conditions.
Source link
MiRus receives FDA breakthrough device designation for posterior cervical spine system
